itopride has been researched along with Critical Illness in 1 studies
Critical Illness: A disease or state in which death is possible or imminent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Itopride, is a prokinetic agent which is different and unique from the available prokinetics because of its dual mode of action as well as its tolerability and safety." | 3.01 | The efficacy and safety of itopride in feeding intolerance of critically ill patients receiving enteral nutrition: a randomized, double-blind study. ( Bassiouny, AM; Darweesh, EAG; El Borolossy, RM; Elmokadem, EM; Hanna, MG; Sabri, NA, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elmokadem, EM | 1 |
| El Borolossy, RM | 1 |
| Bassiouny, AM | 1 |
| Hanna, MG | 1 |
| Darweesh, EAG | 1 |
| Sabri, NA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Study of The Efficacy and Safety of Itopride For Feeding Intolerance in Critically-ill Patients Receiving Enteral Nutrition[NCT03698292] | 60 participants (Anticipated) | Interventional | 2018-10-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for itopride and Critical Illness
| Article | Year |
|---|---|
The efficacy and safety of itopride in feeding intolerance of critically ill patients receiving enteral nutrition: a randomized, double-blind study.
Topics: Benzamides; Benzyl Compounds; Critical Illness; Double-Blind Method; Enteral Nutrition; Humans; Inte | 2021 |